Published in Drug Week, June 11th, 2004
In addition, 60% of patients who were switched to Lexapro responded and more than 40% achieved remission of depressive symptoms after failing initial antidepressant therapy. The findings were presented at the 157th annual meeting of the American Psychiatric Association in New York.
"Forty percent of patients achieving remission from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.